Skip to Main Content

Paper Details

Autoantibodies are highly prevalent in non-SARS-CoV-2 respiratory infections and critical illness.
JCI Insight
8
2023
CTD, CTDs, GM-CSF, IL-6, IgG autoantibodies, SARS-CoV, SARS-CoV-2, Type I IFN, connective tissue diseases, critical illness, critically ill, non-SARS-CoV-2 respiratory infections, patients, viral and nonviral infections, viral, bacterial, and noninfectious critical illness
Author NameAffiliation
Sarah E Chang
Sarah E ChangInstitute for Immunity
Jennifer G Wilson
Jan E CaretteStanford University School of Medicine
Paul J Utz
Paul J UtzInstitute for Immunity
  • 1 - 6

Datasets

Release 1.2